SCD and hepatocellular carcinoma: Similarly, P53 binds to the promoter of SCD1 and inhibits its transcription, thereby mediating lipid metabolism reprogramming and developing resistance tyrosine kinase inhibitor (TKI) induced ferritic anemia in HCC.